Brokerages expect Sientra Inc (NASDAQ:SIEN) to report earnings per share (EPS) of ($0.42) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Sientra’s earnings. The lowest EPS estimate is ($0.47) and the highest is ($0.38). Sientra reported earnings per share of ($0.86) in the same quarter last year, which indicates a positive year-over-year growth rate of 51.2%. The business is scheduled to report its next quarterly earnings results on Tuesday, March 10th.
On average, analysts expect that Sientra will report full-year earnings of ($2.57) per share for the current financial year, with EPS estimates ranging from ($3.01) to ($2.15). For the next fiscal year, analysts expect that the company will report earnings of ($1.55) per share, with EPS estimates ranging from ($1.66) to ($1.32). Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Sientra.
Several brokerages have issued reports on SIEN. Zacks Investment Research raised shares of Sientra from a “sell” rating to a “hold” rating in a report on Tuesday, February 4th. William Blair raised shares of Sientra from a “market perform” rating to an “outperform” rating in a report on Tuesday, November 5th. Finally, BidaskClub downgraded shares of Sientra from a “sell” rating to a “strong sell” rating in a research report on Tuesday, February 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company. Sientra currently has a consensus rating of “Buy” and a consensus price target of $15.11.
Shares of SIEN stock opened at $6.15 on Tuesday. Sientra has a 1 year low of $4.78 and a 1 year high of $11.92. The firm’s fifty day simple moving average is $7.50 and its 200 day simple moving average is $7.21. The firm has a market capitalization of $304.31 million, a P/E ratio of -1.80 and a beta of 0.36. The company has a current ratio of 2.80, a quick ratio of 2.32 and a debt-to-equity ratio of 0.40.
Sientra, Inc, a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
Read More: How Do You Calculate Return on Equity (ROE)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.